🔎 Trials Near Me

Home › Kanser sa Suso › California › Sacramento

Pag-aaral pangklinika para sa Kanser sa Suso sa Sacramento, CA

Isang pag-aaral para sa Kanser sa Suso ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Sacramento. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Nagre-recruitPhase 3
  • University of California, Davis Comprehensive Cancer Center, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06982521

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Nagre-recruitPhase 3
  • Sutter Inst Medical Research, Sacramento
  • School Of Medicine, Sacramento
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05827081

Distance-Based Exercise to Preserve Function and Prevent Disability

Nagre-recruit
  • Kaiser Permanente-South Sacramento, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07059884

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • Mercy Cancer Center - Sacramento, Sacramento
  • Woodland Memorial Hospital, Woodland · 16 mi ang layo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
  • University of California Davis, Sacramento
Edad 30 hanggang 74 · Kababaihan · Na-update Set 21, 2026 · NCT02620852

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Nagre-recruitPhase 3
  • University Of California Davis Health System, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07173751

ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health

Nagre-recruitObservasyonal na pag-aaral
  • UC Davis, Sacramento
Edad 18 hanggang 94 · Kababaihan · Na-update Set 17, 2026 · NCT07505797

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Nagre-recruitPhase 3
  • Dignity Health dba Health Research Institute, Sacramento
  • Sutter Institute for Medical Research, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06492616

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Nagre-recruitPhase 3
  • Kaiser Permanente Downtown Commons, Sacramento
  • Mercy Cancer Center - Sacramento, Sacramento
  • Sutter Medical Center Sacramento, Sacramento
  • at 5 pa
Edad 18 hanggang 60 · Kababaihan · Na-update Set 2, 2026 · NCT05879926

A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
  • University of California, Davis, Sacramento
Edad 25 pataas · Kababaihan · Na-update Set 1, 2026 · NCT03729115

E-Mindfulness Approaches for Living After Breast Cancer

Nagre-recruitPhase 3
  • Kaiser Permanente Downtown Commons, Sacramento
  • Kaiser Permanente-South Sacramento, Sacramento
Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT06748222

Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)

Nagre-recruit
  • University of California, Davis, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 8, 2026 · NCT06103669

UHFUS Characterization of Normal Lymphatic Anatomy

Nagre-recruit
  • University of California Davis Health, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 1, 2026 · NCT07677839

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Nagre-recruitPhase 2
  • University of California - Davis, Comprehensive Cancer Center, Davis · 14 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT01042379

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Nagre-recruitPhase 3
  • Kaiser Permanente Downtown Commons, Sacramento
  • Mercy Cancer Center - Sacramento, Sacramento
  • Sutter Medical Center Sacramento, Sacramento
  • at 4 pa
Edad 50 hanggang 70 · Lahat ng kasarian · Na-update Abr 23, 2026 · NCT04852887

A Study of DB-1310 in Advanced/Metastatic Solid Tumors

Nagre-recruitPhase 1/2
  • University of California, Davis Comprehensive Cancer Center, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 6, 2026 · NCT05785741

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Nagre-recruitObservasyonal na pag-aaral
  • Kaiser Permanente Downtown Commons, Sacramento
  • Mercy Cancer Center - Sacramento, Sacramento
  • Kaiser Permanente-South Sacramento, Sacramento
  • at 1 pa
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06418204

Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

Nagre-recruitPhase 2
  • University of California Davis Comprehensive Cancer Center, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 4, 2026 · NCT06268665

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Nagre-recruitPhase 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 13, 2026 · NCT06778863

Pag-aaral para sa Kanser sa Suso sa ibang lungsod

Iba pang pag-aaral sa Sacramento

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.